ELECTROMEDICAL PRODUCTS INTERNATIONAL, INC.

Electromedical Products International, Inc. specializes in the design, manufacture, and supply of electromedical and electrophysiological devices, with a primary focus on cranial electrotherapy stimulation (CES) and microcurrent therapy systems. The company delivers FDA-cleared therapeutic devices such as the ALPHA-STIM line, which integrate non-invasive neurostimulation technologies for pain management, anxiety, depression, and insomnia. Their technical expertise lies in precision waveform generation, low-current electrical stimulation protocols, and medical-grade hardware integration for clinical and home-use environments. Differentiators include FDA-regulated manufacturing compliance, device portability, and seamless integration with VA and DoD prosthetics and behavioral health programs. The contractor maintains a deep, sustained relationship with the Department of Veterans Affairs, consistently supplying CES and microcurrent stimulation kits for veteran mental health and chronic pain programs. The Department of Defense also procures similar neurostimulation devices for battlefield trauma and neurological rehabilitation. Additional engagements with GSA and NAC FSS reflect established channels for federal medical equipment distribution. Electromedical Products International operates under NAICS 334510, specializing in electromedical apparatus manufacturing, with supplementary activity in surgical instrument manufacturing and medical equipment wholesaling. Their market positioning centers on evidence-based neuromodulation devices for military and veteran healthcare systems, distinguishing them as a niche provider of non-pharmacological therapeutic solutions. As a small business structured as a 2L entity based in Mineral Wells, Texas, the company lacks federal certifications such as 8(a), HUBZone, or SDVOSB. Its geographic footprint is limited to its Texas manufacturing and distribution hub, but its products are deployed nationwide through federal supply channels. The company’s government market presence is defined by reliability in delivering specialized medical devices under strict regulatory frameworks, with no public certifications beyond standard FDA compliance for Class II medical devices.